The head of the Food and Drug Administration (FDA) said on Wednesday that the agency is taking a “risk-based approach” to enforcing current CBD regulations while it continues to pursue alternative pathways that would allow for its lawful marketing. During one of his last days as FDA commissioner, Scott Gottlieb appeared before a House appropriations … Continue reading FDA Chief Explains Agency’s ‘Risk-Based Approach’ To CBD Enforcement